Published in Vaccine Weekly, February 10th, 2010
tick-borne encephalitis (TBE) persists. However, highly effective and well tolerated vaccines are available, offering 99% protection against TBE, experts of the International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE) say.
The ISW-TBE is holding its 12th Annual Meeting in Vienna, Austria, from 28-29 January 2010. In recent years, risk areas of TBE have expanded northward and to higher altitudes - a development thought to be due to climate change. At the same time, TBE incidence has fluctuated
considerably: Europe and Russia reported 12,733...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly